Carboxylic diarythiazepineamines as mixed mu- and delta-opioid receptor agonists
US-11787772-B2 · Oct 17, 2023 · US
This page is not indexed by search engines while we improve data quality.
[b, e]-condensed
[b, e]-condensed · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D281/14 |
| Official title | [b, e]-condensed |
| Display label | [b, e]-condensed |
| Total patents | 14 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is growing.
| Year | Patents |
|---|---|
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Hepatitis b core protein allosteric modulators
US-2023019129-A1 · Jan 19, 2023 · US
Hepatitis B core protein allosteric modulators
US-10947224-B2 · Mar 16, 2021 · US
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
US-2021070703-A1 · Mar 11, 2021 · US
Selective bromodomain inhibition of fungal Bdf1
US-10918647-B2 · Feb 16, 2021 · US
Carboxylic diarythiazepineamines as mixed mu-and delta-opioid receptor agonists
US-2020079745-A1 · Mar 12, 2020 · US
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
US-2019337891-A1 · Nov 7, 2019 · US
Selective bromodomain inhibition of fungal bdf1
US-2019240232-A1 · Aug 8, 2019 · US
Hepatitis B core protein allosteric modulators
US-10183936-B2 · Jan 22, 2019 · US
Hepatitis b core protein allosteric modulators
US-2018273521-A1 · Sep 27, 2018 · US
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
US-2017320818-A1 · Nov 9, 2017 · US
Sulfamoylbenzamide derivatives as antiviral agents against HBV infection
US-9758477-B2 · Sep 12, 2017 · US
Sulfamoylbenzamide derivatives as antiviral agents against HBV infection
US-9399619-B2 · Jul 26, 2016 · US
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
US-2016101074-A1 · Apr 14, 2016 · US